Halozyme Therapeutics shares owned by Mount Yale Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mount Yale Investment Advisors
from 13F filings
Historical chart of Mount Yale Investment Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Mount Yale Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Mount Yale Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $271k | 5.7k | 47.81 |
| 2024-09-30 | $857k | 15k | 57.24 |
| 2022-12-31 | $210k | 3.7k | 56.90 |
More positions owned by Mount Yale Investment Advisors
View all positions for Mount Yale Investment Advisors